Fig. 6From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsRecurrence of novel variants (n = 2356) within Peter MacCallum Cancer Centre patient samples. All variants (black) are further broken down into germline (blue), haematological (green), somatic (red) analyses. The plot highlights the majority of variants are not recurrent (n = 2041) and mostly from somatic analysisBack to article page